Department of Anesthesiology and Pain Medicine, Gachon University of Medicine and Science, Gil Medical Center, Incheon, Korea.
Korean J Anesthesiol. 2011 Apr;60(4):237-43. doi: 10.4097/kjae.2011.60.4.237. Epub 2011 Apr 26.
We compared the continuous cardiac index measured by the FloTrac/Vigileo™ system (FCI) to that measured by a pulmonary artery catheter (CCI) with emphasis on the accuracy of the FCI in patients with a decreased left ventricular ejection fraction (LVEF) and a low cardiac output status during off-pump coronary bypass surgery (OPCAB). We also assessed the influence of several factors affecting the pulse contour, such as the mean arterial pressure (MAP), the systemic vascular resistance index (SVRI) and the use of norepinephrine.
Fifty patients who were undergoing OPCAB (30 patients with a LVEF ≥ 40%, 20 patients with a LVEF < 40%) were enrolled. The FCI and CCI were measured and we performed a Bland-Altman analysis. Subgroup analyses were done according to the LVEF (< 40%), the CCI (≤ 2.4 L/min/m), the MAP (60-80 mmHg), the SVRI (1,600-2,600 dyne/s/cm(5)/m(2)) and the use of norepinephrine.
The FCI was reliable at all the time points of measurement with an overall bias and limit of agreement of -0.07 and 0.67 L/min/m(2), respectively, resulting in a percentage error of 26.9%. The percentage errors in the patients with a decreased LVEF and in a low cardiac output status were 28.2% and 22.3%, respectively. However, the percentage error in the 91 data pairs outside the normal range of the SVRI was 40.2%.
The cardiac output measured by the FloTrac/Vigileo™ system was reliable even in patients with a decreased LVEF and in a low cardiac output status during OPCAB. Acceptable agreement was also noted during the period of heart displacement and grafting of the obtuse marginalis branch.
我们比较了 FloTrac/Vigileo™ 系统(FCI)连续心排量与肺动脉导管(CCI)测量的心排量,重点评估 FCI 在非体外循环冠状动脉旁路移植术(OPCAB)期间左心室射血分数(LVEF)降低和心输出量低的患者中的准确性。我们还评估了几种影响脉搏轮廓的因素,如平均动脉压(MAP)、全身血管阻力指数(SVRI)和去甲肾上腺素的使用对 FCI 的影响。
共纳入 50 例行 OPCAB 的患者(LVEF≥40%患者 30 例,LVEF<40%患者 20 例)。测量 FCI 和 CCI,行 Bland-Altman 分析。根据 LVEF(<40%)、CCI(≤2.4 L/min/m)、MAP(60-80mmHg)、SVRI(1600-2600 dyne/s/cm5/m2)和去甲肾上腺素的使用情况进行亚组分析。
FCI 在所有测量时间点均可靠,总偏差和一致性界限分别为-0.07 和 0.67 L/min/m2,导致误差百分比为 26.9%。LVEF 降低和心输出量低的患者误差百分比分别为 28.2%和 22.3%。然而,SVRI 正常范围外的 91 对数据误差百分比为 40.2%。
即使在 OPCAB 期间 LVEF 降低和心输出量低的患者中,FloTrac/Vigileo™ 系统测量的心排量也可靠。在心脏移位和钝缘支吻合期间,也观察到可接受的一致性。